Advanced therapies for the treatment of hemophilia: future perspectives

Monogenic diseases are ideal candidates for treatment by the emerging advanced therapies, which are capable of correcting alterations in protein expression that result from genetic mutation. In hemophilia A and B such alterations affect the activity of coagulation factors VIII and IX, respectively,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liras, Antonio, Segovia, Cristina, Gabán, Aline S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551751/
https://www.ncbi.nlm.nih.gov/pubmed/23237078
http://dx.doi.org/10.1186/1750-1172-7-97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551751/
https://www.ncbi.nlm.nih.gov/pubmed/23237078
http://dx.doi.org/10.1186/1750-1172-7-97

Ejemplares similares